Drug Shortage Report for CANCIDAS
Report ID | 203308 |
Drug Identification Number | 02244265 |
Brand name | CANCIDAS |
Common or Proper name | caspofungin for injection |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CASPOFUNGIN |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1dose vial |
ATC code | J02AX |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-09-29 |
Actual start date | 2023-09-21 |
Estimated end date | 2023-11-17 |
Actual end date | 2023-10-31 |
Shortage status | Resolved |
Updated date | 2023-11-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-08-30 | English | Compare |
v2 | 2023-08-30 | French | Compare |
v3 | 2023-09-21 | English | Compare |
v4 | 2023-09-21 | French | Compare |
v5 | 2023-09-22 | English | Compare |
v6 | 2023-10-03 | English | Compare |
v7 | 2023-10-03 | French | Compare |
v8 | 2023-10-23 | English | Compare |
v9 | 2023-10-23 | French | Compare |
v10 | 2023-10-27 | English | Compare |
v11 | 2023-10-27 | French | Compare |
v12 | 2023-10-31 | English | Compare |
v13 | 2023-10-31 | French | Compare |
v14 | 2023-10-31 | English | Compare |
v15 | 2023-11-01 | French | Compare |
Showing 1 to 15 of 15